查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1871062

按产品类型、应用、最终用户、材质、涂层和分销管道分類的分流器市场—2025-2032年全球预测

Flow Diverters Market by Product Type, Application, End User, Material, Coating, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，分流器市场规模将达到 4.6677 亿美元，复合年增长率为 5.88%。

关键市场统计数据
基准年 2024 2.9538亿美元
预计年份：2025年 3.1247亿美元
预测年份 2032 4.6677亿美元
复合年增长率 (%) 5.88%

血流导向装置技术及临床应用趋势的全面介绍：变革现代血管内治疗中的动脉瘤管理

血流导向装置已成为治疗复杂动脉瘤的一种变革性血管内治疗选择，将治疗模式从传统的弹簧圈栓塞转变为基于支架的血管重组。这些装置的主要作用是将血流从动脉瘤囊引流开来，同时为内皮化提供支架，最终促进动脉瘤闭塞和血管癒合。过去十年间，从提高编织密度和孔径到改进输送系统，装置技术的不断创新拓展了血流导向疗法的技术可行性和临床应用范围。

深入分析推动血流导向装置生态系统创新和应用的技术、监管和临床变革。

在科技、监管和临床因素的共同推动下，血流导向装置领域正经历着变革性的转变。在技​​术方面，研发人员正在改进结构设计，例如双层和单层编织结构，同时，Pipeline Flex 和 Silk 等衍生的出现正在提升输送性能和生物相容性。材料科学的创新，包括镍钛诺、钴铬合金和铂合金的最佳化应​​用，以及先进表面处理技术的出现，正在提高装置的渗透性和生物相容性。同时，从亲水性涂层到聚合物层等新型涂层技术也被引入，以减少输送过程中的摩擦并改善植入后的血栓形成倾向。

分析 2025 年美国关税如何重塑整个流动转移价值链的供应链韧性、采购行为和商业策略。

2025年美国关税政策对整个血流导向装置价值链产生了重大影响，涵盖从原料采购到医疗设备分销的各个环节。对于依赖钴铬合金、镍钛合金和渗透性铂金等特殊黄金的製造商而言，进口关税的变化推高了投入成本，促使他们重新评估供应商合约。为此，一些器械製造商正在探索近岸外包策略和替代采购安排，以降低其受关税波动的影响，并在维持品管标准的同时，维持利润率结构。

将产品架构、临床适应症、材料科学、涂层策略和通路与市场接受度驱动因素和设计优先事项联繫起来的高解析度細項分析

按产品类型、应用、最终用户、材料、涂层和分销管道对市场进行细分，可以清楚揭示产品性能属性和市场接受度驱动因素，指南产品开发和商业化策略。在考虑产品结构时，层级构造和单层编织结构与 Pipeline Flex 和 Silk 系列等品牌平台并存。编织密度、径向力和输送系统轮廓的设计差异会影响临床医师针对特定形态和解剖挑战的选择。材料成分进一步优化了这些选择，例如，镍钛合金因其超弹性特性而被选择性地用于适应复杂的解剖结构，钴铬合金用于增强特定血管直径的径向强度，铂金则用于增强植入过程中的渗透性。具体而言，双层和单层器械系列在钴铬合金、镍钛合金和铂金配置下进行评估，以平衡可见性、贴合性和结构耐久性。

透过深入分析关键区域的管理体制、临床网路和製造地如何驱动差异化的引进许可和商业化策略，提供区域情报。

区域趋势对美洲、欧洲/中东/非洲和亚太地区的监管时间表、临床应用率和供应链结构都产生了深远的影响。在美洲，监管路径和已建立的临床网路通常能够促进医疗设备迭代改进的快速应用，而大型学术医疗中心和社区医院的采购结构则有显着差异。这种差异促使製造商采用灵活的商业模式，将与机构采购部门的直接合作与门诊医疗机构的定向推广相结合。

深入了解领先的医疗设备製造商如何将产品创新、伙伴关係和上市后证据策略结合，以增强其市场地位和临床价值提案。

领先的医疗设备製造商和生态系统参与者正采取多种策略来保持竞争优势并满足不断变化的临床需求。许多公司优先考虑产品迭代改进（例如改进输送系统以降低体积、透过材料选择提高渗透性以及研究表面改质以影响血栓形成性），同时也在投资产生临床证据，以支持更广泛的标籤声明和与支付方的沟通。与影像提供者和手术系统供应商的策略联盟也在不断增加，旨在将新推出的器械与增强的术中可视化和导航功能相结合。

为製造商、经销商和临床领导者提供切实可行的策略，以提高产品采纳率、增强供应韧性并实现基于证据的报销结果。

产业领导者应优先采取一系列行动，将洞察转化为永续的竞争优势。製造商应继续投资于能够降低手术复杂性、提高可视性并最大限度减少材料用量的器械设计，同时确保结构完整性。同时，投资于完善的临床註册研究和有针对性的随机对照研究，将有助于加强与支付方的沟通，并支持更广泛的临床应用，尤其是在那些长期疗效对评估价值至关重要的解剖区域。

采用透明的多方法调查方法，结合临床医生访谈、监管审查、器械註册分析和供应链资讯分析，以检验策略发现。

本研究综合分析是基于多方面的方法，该方法结合了与关键相关利益者的直接对话和严谨的第二手资料分析。一级资讯来源包括对介入神经放射学和血管临床医生、医院和门诊采购人员以及参与器械策略的高级商业主管的深度访谈。这些访谈旨在揭示关于器材性能、临床决策和采购趋势的细緻观点。

我们简要概述了技术、临床和商业性因素将如何汇聚，从而决定血流导向装置应用和持续价值创造的未来轨迹。

摘要，血流导向装置技术的发展轨迹以器械设计、材料科学和临床证据的进步融合为特征，旨在拓展复杂动脉瘤形态的治疗可能性。同时，关税趋势、不断变化的医保框架以及监管和临床基础设施的区域差异等外部因素，正在影响创新成果转化为患者照护的方式和地点。能够整合供应链韧性、实证实践和客製化商业性策略的相关人员，将更有利于获得持续的临床和商业性价值。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 具有亲水性涂层的下一代薄型血流导向装置的临床应用，以提高血管相容性
  • 生物可吸收血流导向装置的出现，使得无需永久植入即可进行血管重塑。
  • 透过整合术中三维成像和人工智慧演算法来优化血流导向装置放置精度
  • 越来越多的证据表明，血流导向装置具有长期有效性和安全性，这正在推动保险报销。
  • 血流导向装置的应用范围正在扩大，包括小直径远端血管和儿童动脉瘤的治疗。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依产品类型分類的分流器市场

  • 双层
    • 钴铬
    • 镍钛诺
    • 铂
  • 管道柔性
  • 丝绸
  • 单层
    • 钴铬
    • 镍钛诺
    • 铂

第九章 按应用分類的分流器市场

  • 颅内动脉瘤
    • 纺锤形
    • 囊状
    • 颈阔肌
  • 週边动脉瘤
    • 纺锤形
    • 颈阔肌

第十章 依最终用户分類的分流器市场

  • 门诊手术中心
  • 医院
  • 专科诊所

第十一章 依材料分類的分流器市场

  • 钴铬
  • 镍钛诺
  • 铂

第十二章 按涂层分類的导流板市场

  • 裸金属
  • 亲水涂层
  • 聚合物涂层

第十三章 依分销通路分類的分流器市场

  • 直销
  • 医院药房
  • 线上销售
  • 零售药房

第十四章 区域性分流器市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 按组别分類的分流器市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国分流器市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Medtronic plc
    • Stryker Corporation
    • MicroVention, Inc.
    • Balt Extrusion SA
    • Acandis GmbH & Co. KG
    • Phenox GmbH
    • Rapid Medical Ltd.
    • MedAlliance SA
Product Code: MRR-1A1A064C05F2

The Flow Diverters Market is projected to grow by USD 466.77 million at a CAGR of 5.88% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 295.38 million
Estimated Year [2025] USD 312.47 million
Forecast Year [2032] USD 466.77 million
CAGR (%) 5.88%

Comprehensive introduction to flow diverter technology and clinical adoption trends reshaping aneurysm management across modern endovascular practice

Flow diverters have emerged as a transformational endovascular option for the management of complex aneurysms, shifting treatment paradigms away from traditional coil embolization toward scaffold-based vessel reconstruction. At their core, these devices act by diverting hemodynamic flow away from the aneurysm sac while providing a scaffold for endothelialization, ultimately promoting aneurysm occlusion and vessel healing. Over the past decade, iterative device innovations-ranging from refinements in braid density and pore size to enhanced delivery systems-have broadened both the technical feasibility and the clinical indications for flow diversion.

Clinicians now consider flow diverters for lesions that were historically difficult to treat, such as wide-neck saccular aneurysms, fusiform morphologies, and certain peripheral aneurysms. Advances in imaging modalities and periprocedural management have reduced some procedural risks, enabling wider adoption across neurointerventional and vascular surgical practices. Concurrently, materials science has played a pivotal role: nitinol and cobalt chromium form the structural backbone of many modern constructs, while platinum and other radiopaque elements improve visualization during deployment.

As the therapeutic landscape evolves, stakeholders from clinical, manufacturing, and distribution domains are converging to address device-specific performance, patient selection algorithms, and real-world outcomes evaluation. This introduction frames the subsequent analysis by highlighting how device design, clinical practice, and system-level factors interrelate to shape the contemporary use and future trajectory of flow diverters.

Deep analysis of technological, regulatory, and clinical shifts that are collectively accelerating innovation and adoption across the flow diverter ecosystem

The landscape of flow diversion is undergoing a set of transformative shifts driven by concurrent technological, regulatory, and clinical forces. From a technology standpoint, developers are refining structural architectures such as dual-layer constructs and single-layer braids, while product iterations like Pipeline Flex and Silk variants push improvements in deliverability and conformability. Material science innovations, including optimized uses of nitinol, cobalt chromium, and platinum alloys, together with the advent of advanced surface treatments, are enhancing both radiopacity and biocompatibility. At the same time, novel coatings-ranging from hydrophilic finishes to polymeric layers-are deployed to reduce friction during navigation and to modulate thrombogenicity post-implantation.

Clinically, the evidence base has matured beyond early feasibility and pivotal studies to include larger registry datasets and longer-term outcome analyses, which collectively inform guidelines and operator preferences. These clinical data have catalyzed broader consideration of flow diversion for a wider array of aneurysm morphologies, including both saccular and fusiform types, and have prompted multidisciplinary care pathways that integrate neurointerventionalists, vascular surgeons, and critical care teams. Regulatory environments have also adapted; expedited pathways for devices demonstrating clear clinical benefit and iterative approvals for delivery-system enhancements are shortening time-to-adoption in some jurisdictions, while reimbursement structures are evolving to recognize the long-term cost offsets associated with durable aneurysm occlusion.

Operationally, the setting of care is shifting as well. Ambulatory surgical centers and specialty clinics are increasingly capable of supporting select endovascular cases, driven by advances in imaging and anesthesia protocols and a focus on value-based care. Distribution and procurement models are likewise being reconfigured: manufacturers balance direct sales approaches with partnerships to hospital pharmacies and third-party distributors, and digital channels are emerging as complementary routes to reach smaller clinical facilities. Collectively, these shifts are aligning to accelerate innovation cycles, alter competitive dynamics, and demand more sophisticated coordination across clinical, regulatory, and commercial functions.

Analysis of how United States tariff measures in 2025 reshaped supply chain resilience, procurement behavior, and commercial strategies across the flow diverter value chain

The imposition of tariffs in the United States during 2025 has exerted a noticeable influence across the flow diverter value chain, from raw material procurement to device distribution. For manufacturers reliant on specialized metals such as cobalt chromium, nitinol, and radiopaque platinum, changes in import duties have elevated input costs and prompted reassessments of supplier contracts. In response, several device producers are examining nearshoring strategies and alternative sourcing arrangements to mitigate exposure to volatile tariff environments and to preserve margin structures while maintaining quality control standards.

Distribution channels have felt the secondary effects of tariff-driven cost pressures. Hospital procurement teams and ambulatory surgical centers have intensified negotiations around unit pricing and service bundles, seeking predictable total cost of ownership while preserving access to advanced devices. This dynamic has placed increased emphasis on value demonstration in clinical outcomes and on post-market performance data to justify premium pricing or to negotiate favorable purchasing terms. Meanwhile, some manufacturers have adjusted their commercial models-balancing direct sales relationships with hospital pharmacies and retailers against online sales strategies that emphasize transparency and reach.

Regulatory and strategic responses have emerged alongside these commercial shifts. Firms are accelerating investment in manufacturing process efficiencies and design optimizations that reduce material intensity without compromising structural integrity. Clinical teams have highlighted the importance of robust real-world registries to validate device longevity and to support reimbursement discussions. In addition, the tariff environment has catalyzed collaborative conversations between industry and payers about reimbursement frameworks that reflect long-term clinical benefit rather than short-term cost minimization. Taken together, the cumulative impact of tariffs has been to amplify the importance of supply chain resilience, to incentivize design economies, and to sharpen the commercial focus on evidence-driven value propositions.

High-resolution segmentation insights linking product architecture, clinical indication, material science, coating strategies, and distribution pathways to adoption drivers and design priorities

Disaggregating the market by product type, application, end user, material, coating, and distribution channel reveals distinct performance attributes and adoption drivers that inform product development and commercialization strategies. When considering product architectures, dual-layer constructs and single-layer braids coexist with branded platforms such as Pipeline Flex and Silk variants; design differentials around braid density, radial force, and delivery system profile influence clinician preference for specific morphologies and anatomical challenges. Material composition further refines these choices, with nitinol delivering superelastic properties for tortuous anatomies, cobalt chromium providing enhanced radial strength for certain vessel diameters, and platinum employed selectively to enhance radiopacity during deployment. Notably, dual-layer and single-layer device families are each evaluated across cobalt chromium, nitinol, and platinum configurations to balance visibility, conformability, and structural resilience.

Application-based segmentation highlights how clinical indication drives device selection and procedure planning. Intracranial aneurysm treatment remains a core use case, encompassing fusiform, saccular, and wide-neck presentations that demand discrete device attributes and deployment strategies. Peripheral aneurysm applications, present in both fusiform and wide-neck forms, introduce additional considerations related to vessel size, flow dynamics, and post-procedure surveillance pathways. These anatomical distinctions guide multidisciplinary decision-making and inform device labeling, training curricula, and post-market evidence collection.

End-user segmentation-spanning ambulatory surgical centers, hospitals, and specialty clinics-affects not only purchasing pathways but also procedural workflows and device design requirements. Ambulatory settings prioritize low-profile delivery systems and streamlined perioperative protocols that minimize resource utilization, whereas hospitals may favor devices supported by robust clinical data and warranty programs. Specialty clinics, often focused on targeted vascular niches, value devices that offer a favorable balance of cost and clinical performance.

Material-focused segmentation underscores how cobalt chromium, nitinol, and platinum each contribute to device behavior and clinical handling. Coatings comprise another critical dimension: bare metal finishes remain relevant where long-term endothelialization is prioritized, hydrophilic coatings reduce friction during navigation in tortuous anatomies, and polymer coatings are explored for their potential to modulate biological response. Lastly, distribution channel segmentation-direct sales, hospital pharmacy, online sales, and retail pharmacy-shapes commercial engagement models. Direct sales facilitate clinical training and bundled services, hospital pharmacy routes integrate devices into institutional procurement cycles, online sales expand access for smaller providers, and retail pharmacy channels can play niche roles in adjunctive product availability. Understanding how these segmentation layers interact provides actionable insight into product prioritization, regulatory pathways, and commercialization tactics.

Regional intelligence detailing how regulatory regimes, clinical networks, and manufacturing footprints across major global regions drive differentiated adoption and commercialization strategies

Regional dynamics exert a profound influence on regulatory timelines, clinical adoption rates, and supply chain architectures across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, regulatory pathways and established clinical networks often enable rapid uptake of iterative device improvements, while procurement structures differ sharply between large academic centers and community hospitals. This variation drives manufacturers to adopt flexible commercial models that combine direct engagement with institutional purchasing groups and targeted support for ambulatory settings.

Europe, the Middle East & Africa present a heterogeneous landscape where regulatory harmonization efforts coexist with country-specific reimbursement regimes and infrastructure variability. In parts of this region, centralized registries and pan-national clinical collaborations facilitate comparative effectiveness research, which manufacturers leverage to validate device performance across diverse patient populations. Simultaneously, emerging markets within the region show growing interest in locally adaptable solutions that balance cost, durability, and logistical simplicity.

Asia-Pacific demonstrates a mix of rapid technology adoption in advanced urban centers and evolving capability in peripheral healthcare systems. Strong domestic manufacturing capabilities in certain countries support local production and export strategies, while regulatory agencies are increasingly aligning with international standards to expedite approvals. Across all regions, differences in reimbursement frameworks, hospital infrastructure, and clinician training pathways drive divergent uptake patterns, making regional segmentation crucial to tailoring clinical evidence generation, commercial deployment, and post-market surveillance efforts.

Insight into how leading device manufacturers are combining product innovation, partnerships, and post-market evidence strategies to strengthen market positions and clinical value propositions

Leading device manufacturers and ecosystem participants are pursuing multiple pathways to sustain competitive advantage and to address evolving clinical needs. Many firms prioritize iterative product improvements-refining delivery systems for lower profile access, enhancing radiopacity through material selection, and exploring surface modifications to influence thrombogenicity-while concurrently investing in clinical evidence generation to support broader labeling claims and payer engagement. Strategic collaborations with imaging providers and surgical systems vendors are becoming more common, aiming to integrate device deployment with enhanced intraoperative visualization and navigation capabilities.

Corporate development activity is also notable: alliances, licensing arrangements, and selective acquisitions enable companies to fill technology gaps or to accelerate entry into adjacent indications such as peripheral aneurysm treatment. Commercially, organizations are experimenting with hybrid distribution models that combine dedicated clinical support through direct salesforces with scalable online channels for standardized product lines. Post-market surveillance and registry participation are treated as strategic priorities to demonstrate long-term safety and durability, which in turn influence purchasing decisions among hospitals and specialty clinics.

Finally, firms are increasingly aware of the need to align product roadmaps with service offerings, including clinician training programs, reimbursement support, and outcome-monitoring solutions. These integrated approaches address buyer needs holistically and create higher switching costs for customers, while simultaneously generating richer real-world evidence that can be leveraged for regulatory and reimbursement discussions.

Actionable strategic recommendations for manufacturers, distributors, and clinical leaders to enhance product adoption, supply resilience, and evidence-driven reimbursement outcomes

Industry leaders should pursue a set of prioritized actions to convert insights into sustainable advantage. Manufacturers must continue to invest in device architectures that reduce procedural complexity, improve visualization, and minimize material intensity without compromising structural integrity. Parallel investments in robust clinical registries and targeted randomized studies will bolster payer conversations and support broader clinical adoption, particularly for anatomies where long-term outcomes are critical to value assessments.

Commercially, firms should diversify distribution approaches by tailoring direct sales engagements to high-volume centers while leveraging hospital pharmacy pathways and online channels to reach smaller facilities and specialty clinics. Strategic partnerships with imaging and navigation technology providers can create bundled solutions that de-risk adoption for clinicians and improve procedural efficiency. Supply chain resilience should be a continuous priority: nearshoring critical manufacturing steps and diversifying supplier bases for cobalt chromium, nitinol, and platinum will mitigate tariff and logistics exposures.

From a clinical adoption perspective, investing in structured training programs and proctorship models that emphasize patient selection, antiplatelet management, and complication mitigation will accelerate safe uptake. Finally, aligning evidence generation with reimbursement strategies-by demonstrating not just procedural success but downstream reductions in retreatment and complication rates-will facilitate sustainable access across hospitals, ambulatory surgical centers, and specialty clinics.

Transparent multi-method research methodology combining clinician interviews, regulatory review, device registry analysis, and supply chain intelligence to validate strategic findings

This research synthesis is grounded in a multi-method approach that integrates primary stakeholder engagement with rigorous secondary source analysis. Primary inputs include in-depth interviews with clinicians across neurointerventional and vascular specialties, procurement leaders in hospital and ambulatory settings, and senior commercial executives involved in device strategy. These conversations were structured to surface nuanced perspectives on device performance, clinical decision-making, and procurement dynamics.

Secondary research included systematic reviews of peer-reviewed clinical literature, regulatory filings, device safety communications, and procedural guidelines from professional societies. In addition, device registries and publicly available post-market datasets were analyzed to identify trends in utilization patterns and safety signals. Supply chain and materials intelligence was informed by reviews of manufacturing capabilities, trade flow data, and tariff policy disclosures, complemented by interviews with sourcing and operations professionals.

Analytical methods combined qualitative synthesis with triangulation across data streams to validate findings and mitigate bias. Expert panels were convened to test hypotheses and to prioritize the strategic implications of observed trends. Throughout, attention was paid to transparency in data provenance and to acknowledging limitations inherent in public reporting and self-reported clinical outcomes. This methodology ensures that conclusions are both evidence-based and reflective of the operational realities faced by stakeholders across the device ecosystem.

Concise conclusion summarizing how technological, clinical, and commercial forces converge to define future trajectories for flow diverter adoption and sustained value creation

In sum, the trajectory of flow diverter technology is characterized by converging advances in device design, materials science, and clinical evidence that together expand therapeutic possibilities for complex aneurysm morphologies. Simultaneously, external forces-including tariff dynamics, evolving reimbursement frameworks, and regional heterogeneity in regulatory and clinical infrastructure-shape how and where innovations translate into patient care. Stakeholders who integrate supply chain resilience, evidence generation, and tailored commercial approaches will be best positioned to capture lasting clinical and commercial value.

Looking forward, the most successful organizations will be those that view devices not as standalone products but as components of integrated solutions that address clinician workflow, payer requirements, and patient outcomes. Strengthening collaborative partnerships across imaging, clinical training, and post-market surveillance will be essential to sustaining adoption momentum. Ultimately, a disciplined focus on durable clinical benefit, operational excellence, and adaptive commercialization will determine which innovations achieve broad clinical integration and long-term impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Clinical adoption of low-profile, next-generation flow diverters with hydrophilic coatings for improved vessel compatibility
  • 5.2. Emergence of bioresorbable flow diverter technologies to support vessel remodeling without permanent implants
  • 5.3. Integration of intraoperative 3D imaging and AI algorithms for optimized flow diverter deployment precision
  • 5.4. Growing evidence of long-term efficacy and safety outcomes driving payer reimbursement for flow diverters
  • 5.5. Expansion of flow diverter applications into small distal vessels and pediatric aneurysm interventions

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Flow Diverters Market, by Product Type

  • 8.1. Dual Layer
    • 8.1.1. Cobalt Chromium
    • 8.1.2. Nitinol
    • 8.1.3. Platinum
  • 8.2. Pipeline Flex
  • 8.3. Silk
  • 8.4. Single Layer
    • 8.4.1. Cobalt Chromium
    • 8.4.2. Nitinol
    • 8.4.3. Platinum

9. Flow Diverters Market, by Application

  • 9.1. Intracranial Aneurysm
    • 9.1.1. Fusiform
    • 9.1.2. Saccular
    • 9.1.3. Wide Neck
  • 9.2. Peripheral Aneurysm
    • 9.2.1. Fusiform
    • 9.2.2. Wide Neck

10. Flow Diverters Market, by End User

  • 10.1. Ambulatory Surgical Center
  • 10.2. Hospital
  • 10.3. Specialty Clinic

11. Flow Diverters Market, by Material

  • 11.1. Cobalt Chromium
  • 11.2. Nitinol
  • 11.3. Platinum

12. Flow Diverters Market, by Coating

  • 12.1. Bare Metal
  • 12.2. Hydrophilic Coated
  • 12.3. Polymer Coated

13. Flow Diverters Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Hospital Pharmacy
  • 13.3. Online Sales
  • 13.4. Retail Pharmacy

14. Flow Diverters Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Flow Diverters Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Flow Diverters Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Medtronic plc
    • 17.3.2. Stryker Corporation
    • 17.3.3. MicroVention, Inc.
    • 17.3.4. Balt Extrusion S.A.
    • 17.3.5. Acandis GmbH & Co. KG
    • 17.3.6. Phenox GmbH
    • 17.3.7. Rapid Medical Ltd.
    • 17.3.8. MedAlliance S.A.

LIST OF FIGURES

  • FIGURE 1. GLOBAL FLOW DIVERTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FLOW DIVERTERS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL FLOW DIVERTERS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COATING, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COATING, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL FLOW DIVERTERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS FLOW DIVERTERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL FLOW DIVERTERS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. FLOW DIVERTERS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. FLOW DIVERTERS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. FLOW DIVERTERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL FLOW DIVERTERS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL FLOW DIVERTERS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PIPELINE FLEX, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PIPELINE FLEX, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PIPELINE FLEX, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PIPELINE FLEX, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PIPELINE FLEX, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PIPELINE FLEX, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SILK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SILK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SILK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SILK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SILK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SILK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL FLOW DIVERTERS MARKET SIZE, BY FUSIFORM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL FLOW DIVERTERS MARKET SIZE, BY FUSIFORM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL FLOW DIVERTERS MARKET SIZE, BY FUSIFORM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL FLOW DIVERTERS MARKET SIZE, BY FUSIFORM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL FLOW DIVERTERS MARKET SIZE, BY FUSIFORM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL FLOW DIVERTERS MARKET SIZE, BY FUSIFORM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SACCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SACCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SACCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SACCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SACCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SACCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL FLOW DIVERTERS MARKET SIZE, BY WIDE NECK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL FLOW DIVERTERS MARKET SIZE, BY WIDE NECK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL FLOW DIVERTERS MARKET SIZE, BY WIDE NECK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL FLOW DIVERTERS MARKET SIZE, BY WIDE NECK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL FLOW DIVERTERS MARKET SIZE, BY WIDE NECK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL FLOW DIVERTERS MARKET SIZE, BY WIDE NECK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL FLOW DIVERTERS MARKET SIZE, BY FUSIFORM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL FLOW DIVERTERS MARKET SIZE, BY FUSIFORM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL FLOW DIVERTERS MARKET SIZE, BY FUSIFORM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL FLOW DIVERTERS MARKET SIZE, BY FUSIFORM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL FLOW DIVERTERS MARKET SIZE, BY FUSIFORM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL FLOW DIVERTERS MARKET SIZE, BY FUSIFORM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL FLOW DIVERTERS MARKET SIZE, BY WIDE NECK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL FLOW DIVERTERS MARKET SIZE, BY WIDE NECK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL FLOW DIVERTERS MARKET SIZE, BY WIDE NECK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL FLOW DIVERTERS MARKET SIZE, BY WIDE NECK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL FLOW DIVERTERS MARKET SIZE, BY WIDE NECK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL FLOW DIVERTERS MARKET SIZE, BY WIDE NECK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL FLOW DIVERTERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL FLOW DIVERTERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL FLOW DIVERTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL FLOW DIVERTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL FLOW DIVERTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL FLOW DIVERTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL FLOW DIVERTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL FLOW DIVERTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL FLOW DIVERTERS MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL FLOW DIVERTERS MARKET SIZE, BY NITINOL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL FLOW DIVERTERS MARKET SIZE, BY PLATINUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL FLOW DIVERTERS MARKET SIZE, BY BARE METAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL FLOW DIVERTERS MARKET SIZE, BY BARE METAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL FLOW DIVERTERS MARKET SIZE, BY BARE METAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL FLOW DIVERTERS MARKET SIZE, BY BARE METAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL FLOW DIVERTERS MARKET SIZE, BY BARE METAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL FLOW DIVERTERS MARKET SIZE, BY BARE METAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HYDROPHILIC COATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HYDROPHILIC COATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HYDROPHILIC COATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HYDROPHILIC COATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HYDROPHILIC COATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HYDROPHILIC COATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL FLOW DIVERTERS MARKET SIZE, BY POLYMER COATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL FLOW DIVERTERS MARKET SIZE, BY POLYMER COATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL FLOW DIVERTERS MARKET SIZE, BY POLYMER COATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL FLOW DIVERTERS MARKET SIZE, BY POLYMER COATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL FLOW DIVERTERS MARKET SIZE, BY POLYMER COATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL FLOW DIVERTERS MARKET SIZE, BY POLYMER COATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL FLOW DIVERTERS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL FLOW DIVERTERS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL FLOW DIVERTERS MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL FLOW DIVERTERS MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL FLOW DIVERTERS MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL FLOW DIVERTERS MARKET SIZE, BY ONLINE SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL FLOW DIVERTERS MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL FLOW DIVERTERS MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL FLOW DIVERTERS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL FLOW DIVERTERS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL FLOW DIVERTERS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL FLOW DIVERTERS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL FLOW DIVERTERS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL FLOW DIVERTERS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL FLOW DIVERTERS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL FLOW DIVERTERS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS FLOW DIVERTERS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS FLOW DIVERTERS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS FLOW DIVERTERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS FLOW DIVERTERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS FLOW DIVERTERS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS FLOW DIVERTERS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE FLOW DIVERTERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE FLOW DIVERTERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPE FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPE FLOW DIVERTERS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPE FLOW DIVERTERS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPE FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 317. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 318. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 319. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2018-2024 (USD MILLION)
  • TABLE 322. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2025-2032 (USD MILLION)
  • TABLE 323. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2018-2024 (USD MILLION)
  • TABLE 324. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2025-2032 (USD MILLION)
  • TABLE 325. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 326. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 327. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 328. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 329. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 330. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY PERIPHERAL ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 331. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 332. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 333. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 334. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 335. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 336. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 337. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 338. MIDDLE EAST FLOW DIVERTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 339. AFRICA FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 340. AFRICA FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 341. AFRICA FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 342. AFRICA FLOW DIVERTERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 343. AFRICA FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2018-2024 (USD MILLION)
  • TABLE 344. AFRICA FLOW DIVERTERS MARKET SIZE, BY DUAL LAYER, 2025-2032 (USD MILLION)
  • TABLE 345. AFRICA FLOW DIVERTERS MARKET SIZE, BY SINGLE LAYER, 2018-2024 (USD MILLION